Gaujoux-Viala et al. Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2014; 73: 510-515.

Gómez Reino et al. Consenso SER sobre la gestión de riesgo del tratamiento con terapia biológicas en paciente con enfermedades reumáticas. Reumatol Clin. 2011; 7 (5):284-298.

Jansen et al. Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs-a systematic review and network meta-analysis. Health Qual Life Outcomes 2014; 12:102.

Nam et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014; 73:516-528.

Orme et al. Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drugs-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20,50 and 70.

Pierreisnard et al. Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naïve or inadequately responsive to methotrexate. Joint Bone Spine 2013; 80: 386-392.

Ramiro et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2014; 73: 529-535.

Romero et al. Artritis reumatoide. Información para pacientes y familiares. Coordinadora Nacional de Artritis (ConArtritis). 2010. Disponible en: http://www.conartritis.org/wp-content/ uploads/2012/05/informacion_actualizada_pacientes_familiares.pdf

Ruiz-Esquide & Sanmartí. Tabaco y otros factores ambientales en la artritis reumatoide. Reumatol Clin 2012; 8(6):342-350.

Sanmartí R et al. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. Reumatol Clin. 2015; 11(5):279-294.

Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014; 73:492-509.